Table 3. Adverse events (maximum grade attributable to drug).
Adverse event (n=36) | Grade 1, 2, n [%] | Grade 3, 4, n [%] | Overall, n [%] |
---|---|---|---|
Fatigue | 19 [53] | 7 [19] | 26 [72] |
Nausea | 19 [53] | 6 [17] | 25 [69] |
Neuropathy-sensory | 21 [58] | 1 [3] | 22 [61] |
Vomiting | 15 [42] | 4 [1] | 19 [53] |
Anorexia | 15 [42] | 1 [3] | 16 [44] |
Anemia | 11 [31] | 3 [8] | 14 [39] |
Diarrhea | 8 [22] | 5 [14] | 13 [36] |
Hand-foot skin reaction | 8 [22] | 1 [3] | 9 [25] |
Abdominal pain or cramping | 4 [11] | 3 [8] | 7 [19] |
Thrombocytopenia | 7 [19] | 0 [0] | 7 [19] |
Note: one patient who received treatment was missing safety data.